Switch to:
Horizon Pharma PLC (NAS:HZNP)
EV/EBITDA
-832.21 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Horizon Pharma PLC's enterprise value is $1,749.30 Mil. Horizon Pharma PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $-2.10 Mil. Therefore, Horizon Pharma PLC's EV/EBITDA ratio for today is -832.21.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Horizon Pharma PLC's stock price is $13.33. Horizon Pharma PLC's earnings per share for the trailing twelve months (TTM) ended in Sep. 2014 was $-5.01. Therefore, Horizon Pharma PLC's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Horizon Pharma PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=1749.295/-2.102
=-832.21

Horizon Pharma PLC's current Enterprise Value is $1,749.30 Mil.
Horizon Pharma PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was -2.29 (Dec. 2013 ) + 6.99 (Mar. 2014 ) + -1.667 (Jun. 2014 ) + -5.135 (Sep. 2014 ) = $-2.10 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Horizon Pharma PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=13.33/-5.01
=

Horizon Pharma PLC's share price for today is $13.33.
Horizon Pharma PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was -1.58 (Dec. 2013 ) + -3.07 (Mar. 2014 ) + -0.38 (Jun. 2014 ) + 0.02 (Sep. 2014 ) = $-5.01.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Horizon Pharma PLC Annual Data

Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda 0.000.000.000.000.000.000.00-0.69-1.21-15.92

Horizon Pharma PLC Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebitda -1.65-0.88-1.21-1.92-1.98-4.04-15.92-104.06511.09-696.43
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK